Aquestive Therapeutics Inc. (AQST) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts AQST Hot Sheet
Join SI Premium – FREE
Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q1 EPS of ($0.07), $0.06 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $14.4 million versus the consensus estimate of $10.9 million.
For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- enVVeno Medical (NVNO) files $100M mixed shelf
- BofA says CTA Treasury shorts stable, euro short-cover risk rises
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
